As one of the cofounders of Artemis Health and the company’s CEO, Mr. Gordon brings a unique perspective to the world of healthcare and benefits, drawing on his deep experience in design, user research, software engineering, and data analysis. Prior to Artemis Mr. Gordon cofounded EnticeLabs, an online advertising optimization company, and RationalIUX, a software user experience design firm. He also holds a Bachelor’s Degree in Information Systems from Brigham Young University. Mr. Gordon is passionate about empowering employers to fix healthcare through data access and analytics.

Seth is President and Co-Founder of OODA Health. Previous to OODA Health, Seth served as the Vice President of Sales and Alliances for Castlight Health. At Castlight, Seth led the team responsible for market partnerships and key national accounts. Seth was one of the earliest employees at Castlight and served on the leadership team. Seth is currently a member of Castlight's board of directors.

Prior to Castlight, Seth was a management consultant at McKinsey & Company. At McKinsey, Seth was a member of the Healthcare Payer and Provider Practice and a founding member of McKinsey’s Center for Healthcare Reform.

Seth earned an MBA from Harvard Business School as a Baker Scholar and an MPA from Harvard Kennedy School. Seth completed his undergraduate studies at Stanford University as a Phi Beta Kappa.

Kyle Salyers joined Health Catalyst in August, 2014 as a Senior Vice President. Prior to joining Health Catalyst, he was a Co-Founder and the Managing Director of CHV Capital, a venture capital affiliate of Indiana University Health. In addition to Health Catalyst, Kyle led CHV/ Indiana University Health’s investments in a range of healthcare IT and medical device companies, including MedVentive (acquired by McKesson), MindFrame (acquired by Covidien), Perfect Serve, NICO, NeoChord, Par8o, and Celleration. Prior to CHV Capital, he served in a number of leadership positions across government, academia, and in entrepreneurial companies, including as a Special Advisor to the President of Indiana University & Executive Director for Advancing Indiana, Investment Director & Innovation Fellow at Rose-Hulman Ventures and the Rose-Hulman Institute of Technology, Senior Vice President of Thomas P. Miller and Associates, Vice President of the Indiana Technology Partnership, and Economic Development Manager for the City of Indianapolis, Mayor Stephen Goldsmith.

Chris completed his PhD in Bioengineering at the University of Utah in the fall of 2013 before taking a leave of absence from medical school (he was enrolled in the MD/PhD program) to found and grow Recursion. He developed the core technology underlying this venture while in the lab of Dr. Dean Li. Chris comes from a family of entrepreneurs, is a graduate of Rice University with degrees in bioengineering and managerial studies, and recently completed an intense course in entrepreneurship at Stanford GSB. Chris is also a Board Member of CureHHT, a patient advocacy group for Hereditary Hemorrhagic Telangiectasia. Chris enjoys cycling on both the road and the trails that cut through Utah's great wilderness, as well as spending precious time with his family.